Idorsia (XSWX:IDIA) Total Current Liabilities : CHF311.1 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Idorsia's total current liabilities for the quarter that ended in Sep. 2023 was CHF311.1

Idorsia Total Current Liabilities Historical Data

The historical data trend for Idorsia's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Total Current Liabilities Chart

Idorsia Annual Data

Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22

Total Current Liabilities

Get a 7-Day Free Trial 104.85 110.88 127.47 165.14 170.36

Idorsia Quarterly Data

Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23

Total Current Liabilities Get a 7-Day Free Trial 166.01 170.36 165.94 193.49 311.08

Idorsia Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Idorsia's Total Current Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Liabilities = Accounts Payable & Accrued Expense + Short-Term Debt & Capital Lease Obligation

= 31.557 + 8.921

+ Other Current Liabilities + Current Deferred Liabilities

= 129.886 + 0

= 170.4

Idorsia's Total Current Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Current Liabilities = Accounts Payable & Accrued Expense + Short-Term Debt & Capital Lease Obligation

= 18.372 + 206.008

+ Other Current Liabilities + Current Deferred Liabilities

= 86.704 + 0

= 311.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Idorsia Total Current Liabilities Related Terms
Thank you for viewing the detailed overview of Idorsia's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (XSWX:IDIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (XSWX:IDIA) » Definitions » Total Current Liabilities

Comparable Companies

XSWX:XLS XSWX:BSLN XSWX:SANN XSWX:MOLN XSWX:NWRN XSWX:RLF XSWX:EVE XSWX:SPEX XSWX:OBSN XSWX:ADXN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

IDRSF:USA IDIAz:UK 0RQE:UK

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia (XSWX:IDIA) Headlines

No Headlines

Idorsia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Current Liabilities	Get a 7-Day Free Trial															166.01	170.36	165.94	193.49	311.08

Total Current Liabilities	=	Accounts Payable & Accrued Expense	+	Short-Term Debt & Capital Lease Obligation
	=	31.557	+	8.921
	+	Other Current Liabilities	+	Current Deferred Liabilities
	=	129.886	+	0
	=	170.4